Premium
EFFICACY AND SAFETY OF PROLONGED MAINTENANCE WITH SUBCUTANEOUS RITUXIMAB IN PATIENTS WITH RELAPSED OR REFRACTORY INDOLENT NHL: RESULTS OF THE PHASE III MABCUTE STUDY
Author(s) -
Rule S.,
Barreto W.G.,
Briones J.,
Carella A.M.,
Casasnovas O.,
Pocock C.,
Wendtner C.M.,
Zaja F.,
Robson S.,
Tschopp R.R.,
Dreyling M.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.43_2630
Subject(s) - medicine , refractory (planetary science) , rituximab , clinical endpoint , phases of clinical research , gastroenterology , clinical trial , surgery , lymphoma , physics , astrobiology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom